$6.470
0.000 (0.00%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
Soll ich Sinovac Biotech Ltd-Aktien kaufen?
Sinovac Biotech Ltd is currently not a strong buy due to its negative financial metrics, including a forward P/E ratio of 357.14, indicating high valuation concerns. While the company has declared a special cash dividend of $55 per share, which could enhance shareholder confidence, the overall financial performance shows significant risks, particularly with a negative price-to-earnings ratio of -1.87. The main risk is the high forward P/E ratio, suggesting that the stock may be overvalued at its current price.
SVA schloss am Friday bei $6.47, nachdem der Kurs 0.00% gestiegen ist
Sinovac Biotech Ltd (SVA) last closed at $6.47, gaining +0.00%. These facts feed the 1-day and 1-week SVA price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Sinovac Biotech Ltd (SVA) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Saisonalitätsanalyse für SVA
Historically the probability of a positive September return for SVA is 0.00%. January offers the highest probability of a positive month at 0.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.